Article Text

Download PDFPDF
Oral administration of Ag suppresses Ag-induced allergic conjunctivitis in mice: critical timing and dose of Ag
  1. Waka Ishida1,
  2. Ken Fukuda1,
  3. Yosuke Harada1,
  4. Tamaki Sumi1,
  5. Osamu Taguchi1,
  6. Masayuki Tsuda2,
  7. Hideo Yagita3,
  8. Atsuki Fukushima1
  1. 1Department of Ophthalmology, Kochi Medical School, Nankoku, Japan
  2. 2The Division of Laboratory Animal Science, Science Research Center, Kochi Medical School, Nankoku, Japan
  3. 3Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan
  1. Correspondence to Dr Atsuki Fukushima, Department of Ophthalmology, Kochi Medical School, Kohasu, Oko-cho, Nankoku-city 783-8505, Japan; fukusima{at}


Background/aims To investigate the effect of Ag doses and administration time points on oral tolerance induction in experimental allergic conjunctivitis (EAC).

Methods BALB/c mice were actively sensitised twice with ovalbumin (OVA) in alum, and then challenged twice with OVA in eye drops. Twenty minutes after the last challenge, the clinical appearance was evaluated. Twenty-four hours later, the conjunctivas, spleens and blood were collected for histological analyses, cytokine production assays, and measurement of serum Ig levels, respectively. The mice were fed with a high or low dose of OVA before sensitisation (prophylactic treatment). To assess the effect of therapeutic treatment, the high-dose Ag was administered after sensitisation. Control groups received phosphate-buffered saline without OVA. To determine the role of interleukin-10 (IL-10) and transforming growth factor-β (TGF-β) in prophylactic low-dose oral tolerance, mice were injected intraperitoneally with neutralising antibodies during the entire experimental period. To assess the role of regulatory T cells, neonatally thymectomised mice were injected with depleting anti-CD25 monoclonal antibodies before the low-dose prophylactic treatment.

Results OVA-feeding was suppressive even when the mice were treated soon after Ag sensitisation. Both the low and high doses of oral OVA suppressed EAC. High-dose treatment significantly suppressed EAC-related cytokine production and serum Ig levels. IL-10 and TGF-β were less likely to be involved in prophylactic low-dose oral tolerance induction but regulatory T cells played a role.

Conclusions Prophylactic and early therapeutic treatment of OVA feeding suppressed EAC. Both high and low doses of oral OVA induced oral tolerance but with different mechanisms.

  • Conjunctiva
  • Immunology
  • Inflammation
  • Treatment Medical

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.